Combined Point of Care Diagnostic of HIV, HBV and HCV

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Combined Point of Care Diagnostic of HIV, HBV and HCV trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06082336

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screEN…

Prospective, cross-sectional, adaptative study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA IBC (a Multiplex Point-of-C…

France252 participantsStarted 2024-09-16

Treatment: MagIA IBC test in capillary blood, MagIA IBC test in other blood matrices

All recent trials (2 shown)

Not Yet RecruitingNot Applicable

NCT07388979

MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo

Performance study to evaluate the clinical performance of the In-Vitro Diagnostic Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined dete…

Location not specified7,500 participantsStarted 2026-03-01

Treatment: MAGIA H3S